# Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)

Source: https://onco.cc/trials/nct06031181/  
OnCo record `nct06031181` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial in lung cancer, run by Fudan University, now recruiting.

## Summary

Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019) is a phase 3, interventional study registered as NCT06031181 by Fudan University, with a registry enrolment figure of 390 participants, started 2023-03-31 and due to reach its primary completion in 2026-01-01. Interventions recorded: Sublobar Resection. Conditions listed: Lung Adenocarcinoma; Frozen Section; Sublobar Resection. Primary outcome: 5-year recurrence-free survival. Lung eligibility wording from the registry: "Not receiving lung cancer surgery before;". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-25
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT06031181
- Phase: 3
- Setting: Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section: a Single-arm, Multi-center, Phase III Trial
- Sponsor: Fudan University
- Enrolled: 390

## Sources

- ClinicalTrials.gov NCT06031181: https://clinicaltrials.gov/study/NCT06031181

## Connected records

- cancers: [Lung cancer (all types)](https://onco.cc/cancers/lung-cancer/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06031181.json